These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8070161)
1. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Bansal AS; MacGregor AJ; Pumphrey RS; Silman AJ; Ollier WE; Wilson PB Clin Exp Rheumatol; 1994; 12(3):281-5. PubMed ID: 8070161 [TBL] [Abstract][Full Text] [Related]
2. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4. Chomarat P; Briolay J; Banchereau J; Miossec P Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213 [TBL] [Abstract][Full Text] [Related]
3. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis. Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005 [TBL] [Abstract][Full Text] [Related]
4. Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23. Yoshikawa T; Nanba T; Kato H; Hori K; Inamoto T; Kumagai S; Yodoi J Immunomethods; 1994 Feb; 4(1):65-71. PubMed ID: 8069529 [TBL] [Abstract][Full Text] [Related]
5. Rheumatoid factor isotypes in monozygotic and dizygotic twins discordant for rheumatoid arthritis. MacGregor AJ; Ollier WE; Venkovsky J; Mageed RA; Carthy D; Silman AJ J Rheumatol; 1995 Dec; 22(12):2203-7. PubMed ID: 8835549 [TBL] [Abstract][Full Text] [Related]
6. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis. Vaiopoulos G; Boki K; Kapsimali V; Coulocheri S; Papadaki HA; Eliopoulos GD Haematologia (Budap); 1998; 29(2):89-99. PubMed ID: 9728801 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD23 in patients with bullous pemphigoid. Maekawa N; Hosokawa H; Soh H; Kasahara M; Izumi H; Yodoi J; Asada Y J Dermatol; 1995 May; 22(5):310-5. PubMed ID: 7673549 [TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of IgE-binding factor/soluble CD23 in bullous pemphigoid. Furukawa F; Kumagai S; Sakamoto Y; Takigawa M; Imamura S J Dermatol Sci; 1994 Apr; 7(2):150-4. PubMed ID: 8060916 [TBL] [Abstract][Full Text] [Related]
9. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus. Bansal A; Roberts T; Hay EM; Kay R; Pumphrey RS; Wilson PB Clin Exp Immunol; 1992 Sep; 89(3):452-5. PubMed ID: 1387597 [TBL] [Abstract][Full Text] [Related]
10. Impaired release of sCD23 by activated B-cells from RA patients. Rezonzew R; Newkirk MM Clin Immunol Immunopathol; 1994 May; 71(2):156-63. PubMed ID: 8181184 [TBL] [Abstract][Full Text] [Related]
11. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Bansal AS; Ollier W; Marsh MN; Pumphrey RS; Wilson PB Immunology; 1993 Jun; 79(2):285-9. PubMed ID: 8344706 [TBL] [Abstract][Full Text] [Related]
12. CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with interleukin-4, soluble CD23 and tumour necrosis factor alpha levels. Loza E; Tinturé T; Sánchez-Ibarrola A Rheumatology (Oxford); 1999 Apr; 38(4):325-8. PubMed ID: 10378709 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 and soluble CD23 serum levels in asthmatic atopic children. Daher S; Santos LM; Solé D; De Lima MG; Naspitz CK; Musatti CC J Investig Allergol Clin Immunol; 1995; 5(5):251-4. PubMed ID: 8574430 [TBL] [Abstract][Full Text] [Related]
14. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma. Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552 [TBL] [Abstract][Full Text] [Related]
15. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment. Cambridge G; Perry HC; Nogueira L; Serre G; Parsons HM; De La Torre I; Dickson MC; Leandro MJ; Edwards JC J Autoimmun; 2014 May; 50():67-76. PubMed ID: 24365380 [TBL] [Abstract][Full Text] [Related]
16. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis. Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156 [TBL] [Abstract][Full Text] [Related]
17. Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis. Massa M; Pignatti P; Oliveri M; De Amici M; De Benedetti F; Martini A Clin Exp Rheumatol; 1998; 16(5):611-6. PubMed ID: 9779313 [TBL] [Abstract][Full Text] [Related]
18. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. al-Janadi M; al-Wabel A; Raziuddin S Clin Immunol Immunopathol; 1994 Apr; 71(1):33-7. PubMed ID: 8137557 [TBL] [Abstract][Full Text] [Related]
19. Elevated soluble CD23 levels in the sera from patients with localized scleroderma. Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K Arch Dermatol Res; 1996 Feb; 288(2):74-8. PubMed ID: 8932584 [TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia. Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]